[Clinical and biological study of a new vascular protective agent and hypolipemic agent, pyridoxine para-chloro-phénoxy-isobutyrate. (Claresan)].
D000328:Adult; D000368:Aged; D002986:Clinical Trials as Topic; D002994:Clofibrate / Q000627:therapeutic use*; D004038:Diet, Reducing; D004361:Drug Tolerance; D005260:Female; D006801:Humans; D006937:Hypercholesterolemia / Q000188:drug therapy; D006949:Hyperlipidemias / Q000188:drug therapy*; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D011736:Pyridoxine / Q000627:therapeutic use*; D014280:Triglycerides / Q000097:blood; D014652:Vascular Diseases / Q000517:prevention & control
D000960:Hypolipidemic Agents; D014280:Triglycerides; D002994:Clofibrate; D011736:Pyridoxine
Etude clinique et biologique d'un nouveau facteur hypolipémiant de protection vasculaire, le para-chloro-phénoxy-isobutyrate de pyridoxine (claresan)